A few months after raising €200 million in investment capital to boost its pipeline, Spanish drugmaker Almirall has used some of the cash for a bispecific antibody partnership with Singapore’s EpimAb Biotherapeutics.
Copyright © 2024 | WordPress Theme by MH Themes